This compound is used to construct the central pyrazolo[3-c]pyridine core of the GLP-1 receptor agonist. (4S)-5H-Pyrazolo[3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester is a key chiral intermediate in the synthesis of Orforglipron.
5H-Pyrazolo(4,3-c)pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)
| API Name | Orforglipron |
|---|---|
| CAS No | 2212021-61-7 |
| Molecular Formula | C23H28FN5O3 |
| Molecular Weight | 441.5 g/mol |
| Synonyms | tert-butyl (4S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate |
Zoho Contact Form
"*" indicates required fields